Friday, August 14, 2026
Facts you can rely on·101 entities·4,806 sourced facts
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 24, 2025

The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley

View original at finance.yahoo.com
The Zacks Analyst Blog Highlights Invesco, Johnson & Johnson, NiSource, Bunge Global and Morgan Stanley For Immediate Release Chicago, IL – December 24, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • NiSource expects to invest $28 billion in 2026-2030 in modernizing infrastructure to enhance the reliability of its operations

    80% confidence
  • NiSource carries a Zacks Rank #2 (Buy)

    80% confidence
  • The labor market cooled in 2025, with unemployment rising to 4.6%, its highest level in several years, and wage growth trending lower

    80% confidence
  • Morgan Stanley pays out a quarterly dividend of $1.00 ($4.00 annualized) per share, with a 2.26% yield at the current stock price; MS's payout ratio is 41%, with a five-year dividend growth rate of 20.35%

    80% confidence
  • NiSource is benefiting from consistent investments to strengthen its infrastructure and expects to invest $28 billion in 2026-2030 in modernizing infrastructure

    80% confidence
  • NiSource carries a Zacks Rank #2 (Buy)

    80% confidence
  • Strategic alliances and Morgan Stanley's increased focus on less capital market-dependent operations are expected to aid growth, with enhanced capital distribution activities reflecting a solid balance sheet

    80% confidence
  • Real GDP rebounded sharply in the second quarter of 2025, expanding 3.8%, according to the U.S. Bureau of Economic Analysis's third estimate, marking a 0.5-percentage-point upward revision driven primarily by stronger-than-expected consumer spending

    80% confidence
  • Real GDP rebounded sharply in the second quarter of 2025, expanding 3.8%, according to the U.S. Bureau of Economic Analysis's third estimate, a 0.5-percentage-point upward revision driven primarily by stronger-than-expected consumer spending

    80% confidence
  • Inflation in 2025 remained above the Federal Reserve's 2% target, even as price pressures eased slightly later in the year

    80% confidence
  • Johnson & Johnson currently has a Zacks Rank #2 (Buy)

    80% confidence
  • Johnson & Johnson pays out a quarterly dividend of $1.30 ($5.20 annualized) per share, with a 2.52% yield at the current stock price; JNJ's payout ratio is 50%, with a five-year dividend growth rate of 5.39%

    80% confidence
  • Invesco currently sports a Zacks Rank #1 (Strong Buy)

    80% confidence
  • Real GDP growth for 2025 is projected at about 2%, reflecting steady but below-trend expansion compared with historical averages

    80% confidence
  • Inflation is projected to gradually moderate in 2026, allowing the Federal Reserve greater flexibility to pivot toward a more accommodative policy stance

    80% confidence
  • Johnson & Johnson's biggest strength is its diversified business model operating through pharmaceuticals and medical devices divisions with more than 275 subsidiaries

    80% confidence
  • Morgan Stanley currently has a Zacks Rank #2 (Buy)

    80% confidence
  • Zacks top stock-picking strategies have returned average gains of +48.4%, +50.2% and +56.7% per year since 2000, compared to the S&P's +7.7% average gain per year

    80% confidence
  • Invesco's robust AUM balance, diverse product offerings, strong balance sheet and global presence will keep supporting financials, and synergies from acquisitions will keep aiding profitability

    80% confidence
  • Invesco currently sports a Zacks Rank #1 (Strong Buy)

    80% confidence
  • Johnson & Johnson currently has a Zacks Rank #2 (Buy)

    80% confidence
  • Real GDP growth for 2025 is projected at about 2%, reflecting steady but below-trend expansion compared with historical averages

    80% confidence
  • Bunge is executing a fundamental transformation anchored by the Viterra merger, expanding global origination, processing scale and logistics efficiency

    80% confidence
  • Morgan Stanley currently has a Zacks Rank #2 (Buy)

    80% confidence
  • NiSource pays out a quarterly dividend of 28.7 cents ($1.12 annualized) per share, yielding 2.7% at the current stock price; NI's payout ratio is 60%, with a five-year dividend growth rate of 6.22%

    80% confidence
  • Real GDP growth is expected to hover near 2% for 2026, reflecting a slowdown from post-pandemic peaks but signaling continued economic resilience rather than contraction

    80% confidence
  • The labor market cooled in 2025, with unemployment rising to 4.6%, its highest level in several years

    80% confidence
  • Inflation remained above the Federal Reserve's 2% target in 2025, even as price pressures eased slightly later in the year

    80% confidence
  • Johnson & Johnson has more than 275 subsidiaries, reflecting an extremely well diversified business

    80% confidence
  • Invesco pays out a quarterly dividend of 21 cents (84 cents annualized) per share, with a 3.11% yield at the current stock price; IVZ's payout ratio is 44%, with a five-year dividend growth rate of 7%

    80% confidence

Data points we hold from this source